Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients
Figure 5
Kaplan-Meier plots of OS of patients with metastatic NB stratified by levels of sHLA-E and sHLA-F. OS of patients with metastatic NB stratified according to levels of sHLA-E (a) and sHLA-F (b) above (black dots) or below (white dots) the ROC cut-off levels. -axes indicate proportion of alive NB patients, whereas -axes indicate survival time (months). values are indicated where the difference is significant.
